Ester Carballo‐Jane
Impact in
- Physiology top 10%
- Adenosine and Purinergic Signaling
-
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Click Chemistry and Applications
Papers in
-
- Receptor Mechanisms and Signaling 4
- Peroxisome Proliferator-Activated Receptors 3
- Melanoma and MAPK Pathways 3
- Metabolism, Diabetes, and Cancer 2
- Surgery 5
- Cholesterol and Lipid Metabolism 4
- Co-authors
- Silvi Luell (8 shared papers)Andrew K.P. Taggart (9 shared papers)Xinchun Tong (4 shared papers)M. Gerard Waters (9 shared papers)Steven L. Colletti (8 shared papers)James R. Tata (8 shared papers)Kang Cheng (7 shared papers)Ning Ren (5 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (9 papers)Journal of Medicinal Chemistry (1 paper)Hepatology Communications (1 paper)Journal of Cardiovascular Pharmacology and Therapeutics (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United StatesFranceSwitzerland
In The Last Decade
Ester Carballo‐Jane
22 papers receiving 477 citations
Peers
Comparison fields: 5 of 82
- Physiology 25
- Organic Chemistry 133
- Molecular Medicine 22
- Pharmaceutical Science 24
- Molecular Biology 230
Countries citing papers authored by Ester Carballo‐Jane
This map shows the geographic impact of Ester Carballo‐Jane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ester Carballo‐Jane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ester Carballo‐Jane more than expected).
Fields of papers citing papers by Ester Carballo‐Jane
This network shows the impact of papers produced by Ester Carballo‐Jane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ester Carballo‐Jane. The network helps show where Ester Carballo‐Jane may publish in the future.
Co-authors
The 25 scholars most cited alongside Ester Carballo‐Jane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 70 | |
| 2 | 2020 | 66 | |
| 3 | 2009 | 63 | |
| 4 | 2010 | 38 | |
| 5 | 2004 | 27 | |
| 6 | 2010 | 23 | |
| 7 | 2015 | 22 | |
| 8 | 2008 | 20 | |
| 9 | 2011 | 19 | |
| 10 | 2009 | 18 | |
| 11 | 2010 | 17 | |
| 12 | 2007 | 16 | |
| 13 | 2007 | 13 | |
| 14 | 2009 | 13 | |
| 15 | 2005 | 12 | |
| 16 | 2006 | 11 | |
| 17 | 2009 | 10 | |
| 18 | 2010 | 10 | |
| 19 | 2021 | 8 | |
| 20 | 2019 | 7 |
About Ester Carballo‐Jane
Ester Carballo‐Jane is a scholar working on Molecular Biology, Surgery, Endocrinology, Diabetes and Metabolism, Oncology and Epidemiology, having authored 22 papers that have together received 490 indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (4 papers), Receptor Mechanisms and Signaling (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Melanoma and MAPK Pathways (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), PARP inhibition in cancer therapy (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Physiology (25 citations), Organic Chemistry (133 citations), Molecular Medicine (22 citations), Pharmaceutical Science (24 citations) and Molecular Biology (230 citations). Ester Carballo‐Jane has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Silvi Luell, Andrew K.P. Taggart, Xinchun Tong, M. Gerard Waters, Steven L. Colletti, James R. Tata, Kang Cheng, Ning Ren, Songnian Lin and Kingshuk Dutta. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Hepatology Communications, Journal of Cardiovascular Pharmacology and Therapeutics and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.